ProQR Therapeutics (PRQR) Shareholder's Equity Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.47% |
| Dec 31, 2024 | -10.17% |
| Dec 31, 2023 | -12.91% |
| Sep 30, 2023 | -14.31% |
| Jun 30, 2023 | -13.86% |
| Mar 31, 2023 | -11.18% |
| Dec 31, 2022 | -13.15% |
| Sep 30, 2022 | -0.58% |
| Jun 30, 2022 | 5.51% |
| Mar 31, 2022 | 10,606.27% |
| Dec 31, 2021 | 7.26% |
| Sep 30, 2021 | 10,732.71% |
| Jun 30, 2021 | 73.37% |
| Mar 31, 2021 | 18.23% |
| Dec 31, 2020 | 13.34% |
| Dec 31, 2019 | 21.88% |
| Dec 31, 2018 | 2.43% |
| Dec 31, 2017 | -30.30% |